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 SUMMARY 
In osteoporotic bone, bone resorption exceeds bone formation resulting in decreased 
bone volume and bone contact in the peri-implant region. Subsequently, implant 
loosening may occur. Current approaches to reduce the effect of remodelling on 
secondary implant stability focus mainly on pharmaceutical methods. In this study we 
investigated a surgical alternative based on particles of a non-resorbable, 
osteoconductive hydroxyapatite ceramic (HA) clinically used as bone filler. We 
hypothesized that the presence of such particles could help maintaining a denser and 
more functional peri-implant bone structure and shift remodelling events. Threaded 
titanium screws were implanted into the proximal tibial metaphysis of four months old 
Wistar rats, four weeks after ovariectomy. In the right tibia, the drill hole was filled 
with HA particles before screw insertion, while the left tibia served as a control 
without HA particles. Rats were sacrificed at five different time points in the following 
eight weeks. Histological analysis demonstrated that during the remodelling phase 
the amount of newly formed bone was significantly higher on the HA over the control 
side. These results indicate that HA particles are able to induce and maintain for a 
longer time a denser peri-implant bone mantel in osteoporotic bone, which may have 
significant implications in implant anchorage and in prevention of implant migration 
and cut-outs. 
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 INTRODUCTION 
Osteoporosis is a systemic skeletal disease characterized by low bone mass and 
micro-architectural deterioration of bone tissue with a consequent increase of bone 
fragility and susceptibility to fractures. Osteoporosis affects about 75 million people in 
Europe, Unites States and Japan [1], mostly aged 50 and older. Of the 10 million 
Americans estimated to have already osteoporosis, 80 % are women [2]. The annual 
incidence of osteoporotic fractures exceeds 1.5 million in the Unites States [3]. In 
Switzerland, the total estimated cost due to osteoporosis and related fractures was 
357 million CHF and represented the leading causes of direct medical costs [4]. Most 
of them are from low-energy falls, including especially proximal femur fractures, spine 
and distal radius fractures, but any bone can be affected [2,3,4]. Fractures resulting 
from osteoporosis generally involve the metaphyseal regions of the bones. These 
regions are affected earlier and even more profoundly during the development of 
osteoporosis. They consist mostly of cancellous bone, which offers a greater surface 
area for bone turnover compared with the compact cortical bone of the diaphysis. 
Therefore, when the bone turnover mechanisms are no longer balanced as in the 
case of osteoporosis, and bone resorption exceeds bone formation, the loading 
capability of cancellous bone is more rapidly compromised [2,5]. Osteoporotic 
fractures cost the United States health care system approximately $17 billion 
annually, with an increase of annual cost projected to approach $50 billion by the 
year 2040 [6]. 
In osteoporotic fracture repair, failure rates of up to 50% have been reported, mostly 
due to an implant pull-out or cut-through [5,7]. One of the reasons for this is the 
altered remodelling condition in osteoporotic bone, whereby bone resorption exceeds 
bone formation [8]. Consequently, due to the remodelling of woven bone, consisting 
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 of a disorganized structure, into the highly organized structure of lamellar bone, bone 
volume, bone mineral density and bone contact decrease in the peri-implant region 
[9]. As a result, the supporting ability of the implant is reduced and loosening of the 
implant may occur.  
There are many different approaches to improve implant stability in the osteoporotic 
patient. Some studies are based on pharmaceutical methods with the use of 
estrogen, calcitonin, parathyroid hormone or biphosphonates administration 
[10,11,12,13]. Other groups are focusing on the features of implant surfaces (e.g. 
hydroxyapatite coated screws) [14,15], or combine this with the treatment of 
prostaglandin receptor agonists [16]. Injectable bone substitutes are also of interest 
for this purpose [17].  
Endobon® (Biomet Orthopaedics GmbH, Kerzers, Switzerland) is a commercially 
available non-resorbable hydroxyapatite ceramic (HA) derived from bovine 
cancellous bone. The basic and highly attractive profile of this material is due to its 
lack of local or systemic toxicity and inflammatory body response and its apparent 
ability to become directly bonded to bone. A series of animal and clinical trials 
verified its good biocompatibility, osteoconductive and even osteoinductive character 
[18,19,20]. It is clinically used since 1991 as bone filling material for the management 
of bone defects especially at tibia plateau fractures, calcaneal and distal radius 
fractures as well as bone cysts [21,22].  
The purpose of this study was to determine whether HA particles inserted around a 
screw could induce an increase in peri-implant bone mass and bone-to-implant 
contact in an osteoporotic rat model. Previous studies with HA-coated implants 
demonstrated higher bone-to-implant contact which led to a better implant stability 
compared to uncoated implants [15,23]. Therefore, we hypothesized that the 
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 combination of HA’s osteoinductive and osteoconductive properties together with the 
larger available surface offered with loose particles compared to an implant coating 
would induce more bone formation, both in direct contact with the implant surface as 
well as between the bricks of HA. Another study showed that during the remodeling 
phase bone volume and bone-to-implant contact were reduced in osteoporotic bone 
compared to sham-operated animals [14]. Thus, we hypothesized that the 
incorporation of non-resorbable HA particles within the newly formed bone might act 
as a barrier to osteoclastic activity reducing bone resorption during the remodelling 
phase.  
If our hypothesis were proven true, the presence of HA particles could offer a double 
positive effect on implant anchorage: 1) directly augment peri-implant bone material 
delivering a stronger frame for screw stability and 2) preserve more bone for a longer 
time in the peri-implant region by affecting remodeling. If screw stability in 
osteoporotic bone were improved and prolonged by the presence of HA particles, a 
fracture would have more time to heal before bone loosening processes of 
osteoporotic disease could lead to implant failure. 
 
This thesis research work was part of a larger study. Surgery and pQCT were done 
by Dr. Melanie Pucher. The histological analysis was done by the author. 
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 MATERIAL AND METHODS 
Rat Model 
The procedure for animal care, experimental protocol and euthanasia in this study 
was approved by the Animal Experimentation Commission of the Veterinary Office of 
the Canton of Grison, Switzerland and followed the guidelines of the Swiss Federal 
Veterinary Office for the use and care of laboratory animals. Twelve week old female 
Wistar rats were purchased from RCC (Resulting & Consulting Company AG, Basel, 
Switzerland). They were acclimatized for four weeks, housed in Makro Type 4 cages 
in groups of four and fed with standard rodent chow (Provimi, Provimi Kliba AG, 
Kaiseraugust, Switzerland) and water ad libitum. The rats were divided randomly into 
five groups of bilateral ovariectomized (OVX) animals (n=40), representing the 
different time-points of euthanasia after implantation and one group (n=8) of sham 
animals. Four weeks were then allowed to pass prior to implantation to induce 
significant bone loss in the OVX animals. The osteoporotic state of each animal was 
verified with in vivo bone mineral density (BMD) measurements of the distal femoral 
metaphyses at the time of ovariectomy as well as four weeks later using a peripheral 
quantitative computed tomography (pQCT) system (XtremeCT®, SCANCO Medical, 
Brüttisellen, Switzerland). Sham animals were then euthanized and OVX animals 
received titanium implants into the left and right proximal metaphysis of the tibia. 
Prior to screw implantation in the right tibia, the drill-hole was filled with 6mg HA 
particles. Animals were sacrificed either at 1 hour, 2, 4, 6 or 8 weeks post 
implantation by CO2 inhalation (Fig. 1). The proximal tibiae were explanted, freed 
from soft tissue and fixed in methanol for histological preparation. 
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Fig. 1: Experimental design. Ovariectomy (OVX) or sham operation (SHAM) at 12 
weeks, screw implantation four weeks later, and sacrifice at five different time points.  
 
Implantation 
Under aseptic conditions, a bilateral anteromedial approach was made to gain 
access to the proximal medial aspect of the tibia metaphysis. A hole with a diameter 
of 1.1 mm was drilled through one of the cortices using a custom made surgical 
aiming device (AO Development Institute, Davos, Switzerland) for reproducible screw 
positioning (Fig. 2). Profuse saline irrigation was applied to avoid bone thermal 
necrosis (Fig. 3). A self-tapping titanium screw (Ø 1.7 x 5 mm) was inserted 
bilaterally (Synthes®, Oberdorf, Switzerland). A 1 mm thick polyethylene washer was 
placed under the screw head, and acted as a place-holder for subsequent pull-out 
tests to measure ultimate force and stiffness of the anchorage (Fig. 2). The drill-hole 
in the right tibia was filled with 6 mg HA ceramic particles prior to screw insertion, 
whereas the left tibia served as control and the screw was implanted without HA 
particles (Fig. 2). Fascial and cutaneous tissues were closed in two separate layers.  
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Fig. 2: Threaded titanium implant with polyethylene washer (A). Custom made jig for 
accurate and reproducible screw insertion, placed at the proximal tibia of the rat (B). 
 
 
Fig. 3: Surgical procedure: screw insertion under saline irrigation in the proximal right 
tibia using a custom made jig. 
 
HA particles 
Endobon® (Biomet Orthopaedics GmbH, Kerzers, Switzerland) is a non-resorbable 
hydroxyapatite ceramic (HA) derived from bovine cancellous bone. These natural 
particles with a size of approximately 1.5 mm are modified through physicochemical 
treatment such as pyrolysis of over 900 °C followed by a vitrification process of 1200 
°C to remove potential pathogens [24]. 
 The purchased particles were ground and separated using two sieves (Fritsch 
GmbH, IDAR-Oberstein, Germany) with a mesh width of 63 and 100 μm. Particles 
remaining between those sieves were gas-sterilized and 6 mg samples were 
prepared. 
 
Fig. 4: Endobon granules (Biomet, Switzerland) after grinding and sieving 
procedures. 
 
pQCT 
pQCT was performed using an XtremeCT® (Scanco Medical, Brüttisellen, 
Switzerland). This scanning system consists of a two-dimensional detector array with 
3072x255 elements in combination with a microfocus X-Ray-tube having a spot size 
of 70 μm, enabling simultaneous acquisition of a stack of parallel CT slices. The rat 
was positioned on an in-house custom made holder made of plexiglas, which allowed 
consistent and precise positioning of the rat leg. The longitudinal axis of the left leg 
was aligned perpendicular to the scanner beam. Fifty-three cross-sectional slices 
(corresponding to a length of 2 mm) were collected at the distal femoral metaphysis 
with an isotropic voxel resolution of 41 μm and a pixel matrix of 3072x3072, using an 
effective energy of 60 keV and a current intensity of 900 μA. The total scanning time 
was 10 minutes. The resulting gray-scale images were then processed using a 
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Gaussian low-pass filter (sigma=0.7, support=1) to remove noise, and apparent bone 
mineral density (BMD) was calculated for the cancellous bone region. For accurate 
matching of the 2-mm-long region of interest (ROI), an anatomical reference point 
was defined. The most proximal aspect of the distal femoral growth plate was chosen 
for this landmark. 
Fig. 5: XtremeCT and mobile anaesthesia device for in vivo pQCT measurements 
(A). Plastic holder to scan the distal femur in a consistent and repeatable way while 
keeping the rat anaesthetized (B). 
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Histology 
Processing 
Tibiae (n=8 for each time point and group) were fixed in methanol, embedded 
undecalcified in polymethylmethacrylat (PMMA) and serially sectioned to a thickness 
of 250-300 μm using a circular saw (Leitz SP 1600 Saw microtome®, Leica AG, 
Glattbrugg, Switzerland) (Fig. 6). Two mid-sagittal sections of each screw were 
ground and polished to a final thickness of approximately 120-160 μm (Exakt Micro 
Cutting-Grinding System®, Exakt Apparatebau, Norderstedt, Germany) (Fig. 7).  
 
Fig. 6: Circular saw (Leica, Switzerland) (A). Sectioning procedure of one sample (B). 
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Fig. 7: Sample ground under water irrigation (Exakt Apparatebau, Germany) (A). 
Sample was held on the grinding machine by vacuum (B).  
 
Each section was stained for microscopic observation. The surface was etched with 
1% formic acid (Fluka, Buchs, Switzerland) for 30 seconds and rinsed with deionized 
water. For quantitative morphological analysis sections were stained with 1% 
Toluidine blue (Fluka) for 17 minutes and blot dried after washing in deionized water. 
For qualitative evaluation and comparison of cell activity, sections were blot dried, 
and stained with 15 % Giemsa (Fluka) for 45 minutes under 57ºC heat. After 
controlling the intensity of Giemsa under light microscopy, the samples were stained 
with 1% Eosin Yellowish (Fluka) for three minutes. Finally, the sections were rinsed 
in increasing ethanol concentrations. 
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Analysis 
Combining transmitted bright field and reflected dark field microscopy (Axiotech® 
Imaging microscope, Carl Zeiss AG, Feldbach, Switzerland), 12-14 images for each 
section were collected at x100 magnification using AxioVision software (Carl Zeiss 
AG, Feldbach, Switzerland). Those images were then aligned and stitched together 
using Adobe® Photoshop (Adobe Systems GmbH; Zurich, Switzerland) (Fig. 8).  
 
1 mm 
Fig. 8: Twelve images of one section collected at x100 magnification and stitched 
together. One displaced image to highlight the size of a stitched image (toluidine 
blue, original magnification x100). 
 
A 500 μm thick peri-implant ROI was measured from the inner diameter of the screw. 
Two sub-regions were defined to separate the threaded region, where the full thread 
began by screening all the samples, in a proximal and distal part (Fig. 9). The exact 
same threaded region with a length of 1900 μm was selected for all samples. 
Lamellar bone, woven bone, HA particles and mineralized epiphyseal cartilage were 
differentiated and manually contoured within the ROI (Fig. 10).
  
 
Fig. 9: Overview of the position of the screw with its caption in the proximal tibia with 
marked threaded region of interest (A). Two 500 µm thick peri-implant sub-regions 
with a length of 1900 µm (B): proximal region (yellow), distal region (green) (toluidine 
blue, original magnification x100). 
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Fig. 10: A: control side; B: HA side: Differentiation and manual contouring of new 
woven bone (fuchsia), new lamellar bone (maroon), mineralized epiphyseal cartilage 
(purple), primary remodelled epiphyseal bone (olive) and HA particles (aqua) in the 
threaded region (toluidine blue, original magnification x100).  
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 For each of the sub-regions the amount of bone material representing the percent 
surface occupied by each bone type and HA particles were quantified. The contact 
rate, i.e. the percent of screw surface covered by bone types and HA particles was 
also quantified at all time-points. Following parameters were assessed using a 
custom-made macro (KS 400 3.0, Carl Zeiss AG, Feldbach, Switzerland) (Table 1).  
 
measured parameters (pixel) definition 
Area of sub-regions Total area of each of the two sub-regions. 
Area of bone types and HA Total area of either woven bone, lamellar 
bone, primary remodelled lamellar bone, 
epiphyseal cartilage or HA particles within 
each sub-region. 
Implant surface Total length of implant’s outline in each sub-
region. 
Contact length of bone types and 
HA 
Total length of implant’s perimeter in contact 
with a specific type of bone or HA. 
  
calculated parameters (%)  
Percent area Area of a specific bone type or HA divided by 
area of a sub-region. 
Percent contact Contact length of a specific bone type or HA 
divided by implant’s perimeter. 
 
Table 1: Measured and calculated parameters assessed with the quantitative 
evaluation protocol.  
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 Toluidine blue sections of the proximal tibiae were additionally examined using a 
transmitted bright field macrofluoroscope (MacroFluo™, Leica Microsystems, 
Glattbrugg, Switzerland) to estimate the longitudinal bone growth rate. The distance 
between screw axis and growth plate of the proximal tibia was defined as the mean 
between the largest and smallest distance (Fig. 11).  
 
Fig. 11: Screw positioned with its caption in the proximal tibia (control side). 
Estimated longitudinal bone growth rate: the distance was defined as the mean (blue 
line) of the largest (right yellow line) and smallest (left yellow line) distance between 
screw axis and growth plate (green line: screw diameter) (toluidine blue, original 
magnification x16).  
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 Samples stained with Giemsa/Eosin were qualitatively evaluated using the same 
combined transmitted bright field and reflected dark field microscopy (Axiotech® 
Imaging microscope, Carl Zeiss AG, Feldbach, Switzerland) as for the analysis of 
toluidine blue staining sections with a magnification between 25 and 500 (Fig. 12). 
 
Fig. 12: Overview of the peri-implant region (Giemsa/Eosin, original magnification 
x25). 
 
First, the sections were screened with respect to cellular activities, especially 
inflammation, fibrosis and other adverse effects, but also with regard to remodelling 
units due to the presence of HA ceramic. Moreover, as an additional staining, the 
results of the quantitative analysis could be supported and visualized, e.g. bone 
formation during the experimental period.  
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 Statistical analysis 
Analyses of the quantitative results were carried out using SPSS software (SPSS 
Science, 14.0 for Windows Chicago, IL, USA). A p-value of 0.05 was used as a 
threshold for statistical significance. Deviations from normal distribution were 
determined with Shapiro-Wilk test. To analyse the difference in peri-implant bone 
mantel or bone contact over time and between treatment groups an analysis of 
variance was performed with treatment and time as factors in a full factorial General 
Linear Model using a Tukey HSD post-hoc test. In the case of significant interaction 
between the two factors, a One-Way ANOVA with Tukey HSD post-hoc test for “time” 
and a paired T-test for “treatment” were performed separately.  
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RESULTS  
pQCT 
Ovariectomy in rats caused a mean decrease in apparent cancellous bone mineral 
density of 33.9% at the distal femoral metaphyses after four weeks compared to age-
matched sham operated animal. Based on the definition of the World Health 
Organization, the resulting T-score of -2.8 (i.e.: OVX-group 324±56 mgHA/ccm vs. 
SHAM-group 491±60 mgHA/ccm) corresponds to an osteoporotic state of the bone 
tissue (Fig 13).  
 
Fig. 13: Cross-section of a sham-operated (A) and an ovariectomized (B) sample. 
Apparent decrease of cancellous bone mineral density (within contour) in the distal 
femoral metaphysis (B). 
 Histological analysis 
Data from HA and control side at all time points were normally distributed. 
1. Quantitative Analysis 
1.1. Bone mass and contact rate 
 
Results from the quantitative analysis done with toluidine blue staining demonstrated 
that the total amount of peri-implant newly formed bone, which results from the 
addition of newly formed lamellar and woven bone together, was significantly higher 
(p < 0.001) in the HA side compared to the control side between six and eight weeks 
after screw insertion (Fig. 14).  
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Fig. 14: Amount of newly formed bone (i.e. lamellar bone and woven bone added 
together) in the thread region (—: HA side, ---: control side). Error bars indicate 
standard deviation (SD). 
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 Lamellar bone significantly increased with time in a similar way on both sides (p = 
0.001). Woven bone increased abundantly and also in a similar way during the first 
two weeks, however, it was subsequently resorbed differently (p = 0.001). Woven 
bone area percentage remained significantly higher on the HA side compared to the 
control side for the remaining experimental period (p < 0.001) (Fig. 15).  
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Fig. 15: Amount of woven bone (red) and lamellar bone (green) in the thread region 
(—: HA side, ---: control side). Error bars indicate standard deviation (SD). 
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 Regarding the contact rate of newly formed bone, no significant differences were 
detected between both groups over the whole experimental period. Contact rate 
increased during the first four weeks after screw insertion and stayed nearly constant 
for the remaining experimental period. However, normalizing contact rate to the 
available surface (= total surface minus surface of the implant occupied by HA 
particles), showed that significantly more new bone was in contact with the implant in 
the HA side at week 6 and 8 (p = 0.002 and p = 0.002) compared to the control side 
(Fig. 16).  
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Fig. 16: Contact rate. Percentage of screw contour covered with HA particles (violet), 
newly formed bone (woven bone and lamellar bone added together, —: HA side, ---: 
control side) and newly formed bone normalized on the available surface after 
exclusion of the contour covered by HA particles (blue). Error bars indicate standard 
deviation (SD). 
 25
 The amount of woven bone in contact with the implant increased significantly on both 
sides after two weeks (p < 0.001), while lamellar bone showed a significant and 
substantial increase two weeks later (p < 0.001). At week 6 and 8 after implantation, 
significantly more woven bone (p = 0.002 and p = 0.004) was in contact with the 
implant on the HA side, while the contact rate of lamellar bone was significantly 
higher on the control side (p = 0.002 and p < 0.001) (Fig. 17). 
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Fig. 17: Contact rate. Percentage of screw contour covered with woven bone (red) or 
lamellar bone (green) in the thread region (—: HA side, ---: control side). Error bars 
indicate standard deviation (SD). 
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 One hour after implantation 
In both groups (i.e. with and without HA particles), most of the cancellous material 
consisted of primary remodelled lamellar bone and mineralized epiphyseal cartilage. 
Due to implant insertion, trabeculae were broken and displaced between the screw 
threads (Fig. 18). 
 
Fig 18: Control side (top and bottom): one hour after implantation. Preexisting 
cancellous bone (arrows) partially destroyed and displaced (toluidine blue, original 
magnification x100). 
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 In the HA side, the HA particles were mostly concentrated between the threads of the 
screw. Due to the presence of HA, the cancellous bone was placed more marginal 
compared to the control side (Fig. 19). 
 
Fig. 19: HA side (top and bottom): one hour after implantation. Preexisting cancellous 
bone (red arrows) intensively destroyed and displaced. The inserted HA particles 
assembled closely to the implant surface (yellow arrows) (toluidine blue, original 
magnification x100). 
 
No differences could be detected concerning the amount of newly formed bone due 
to the early time of bone healing in both sides (2.7% and 2.4%, control and HA side, 
respectively) (Fig. 14). Additionally, hardly any contact of newly formed woven bone 
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(0.2% and 0.2%, control and HA side, respectively), lamellar bone (0.0% and 0.1%, 
control and HA side, respectively) and HA particles (2.3%) with the implant surface 
was observed at this time point (Fig. 16, 17). 
 
Two weeks after implantation 
In the control side, a large amount of newly formed woven bone was observed 
around the implant. A small amount of newly formed lamellar bone surrounded 
primary remodelled bone and mineralized epiphyseal cartilage, both representing the 
cancellous bone material before screw implantation. Some trabeculae were 
connected to each other, forming a network and extending in direction of the implant. 
Bone-free implant surface was covered with loose connective or marrow tissue (Fig. 
20). 
  
Fig. 20: Control side (top and bottom): two weeks after implantation. Newly formed 
woven bone in contact with implant surface (red arrows). Trabeculae with remnants 
of epiphyseal cartilage extending towards the implant (yellow arrows) (toluidine blue, 
original magnification x100). 
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 In the HA side, newly formed woven bone filled up the interstitial space between the 
HA particles themselves and between HA particles and implant surface (Fig. 21). 
 
Fig. 21: HA side (top and bottom): two weeks after implantation. Newly formed woven 
bone outlining HA particles and implant surface (red arrows) (toluidine blue, original 
magnification x100). 
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 In both sides woven bone amount increased significantly (p < 0.001) between one 
hour (2.0% and 2.0 %, control and HA side, respectively) and 2 weeks after 
implantation (20.8% and 26.3%) (Fig. 15). The amount of newly formed bone (woven 
and newly formed lamellar bone added together) was significantly but not 
substantially higher with HA (27.7%) compared to control (24.0%) (p = 0.048) (Fig. 
14). With regard to contact rate, a significant increase (p < 0.001 and p < 0.001) of 
woven bone was observed, from 0.2% and 0.2% to 33.0% and 38.9%, control and 
HA side respectively. Instead, the amount of lamellar bone in contact with the implant 
surface did not show any significant change (Fig. 17). The contact rate of newly 
formed lamellar and woven bone together was not different (p = 0.823) in both sides 
(38.8% and 39.7%, control and HA side, respectively). HA particles represented a 
contact rate of 10.79% to the implant surface (Fig. 16). 
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Four weeks after implantation 
Newly formed bone on the surface of existing cancellous bone showed increased 
thickness compared to the two weeks old specimens. In the control side, lamellar 
bone surrounded extensively woven bone and got in partial contact with the implant 
surface (Fig. 22). 
 
Fig. 22: Control side (top and bottom): four weeks after implantation. Newly formed 
lamellar bone, surrounding trabeculae with remnants of epiphyseal material and 
woven bone (red arrows), in partial contact with the implant surface (yellow arrows) 
(toluidine blue, original magnification x100). 
 In the HA group, woven bone was filling up the space between the HA particles. 
Woven bone and HA particles covered most of the implant surface. Instead, new 
lamellar bone was found on the outside of the peri-implant structure consisting of HA 
particles and woven bone and surrounded preexisting cancellous bone. Only few 
lamellae were in contact with the implant surface, especially in regions with less HA 
particles (Fig. 23). 
 
Fig. 23: HA side (top and bottom): four weeks after implantation. Thick layers of 
newly formed lamellar bone on the outside of the peri-implant structure formed by HA 
particles and woven bone. Lamellae surrounded HA, woven bone and epiphyseal 
material (red arrows). Space between HA filled up with newly formed woven bone 
(yellow arrows) (toluidine blue, original magnification x100). 
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 When comparing the amount of newly formed bone, both sides showed a decrease 
of woven bone between two and four weeks after implantation, but only significantly 
in the control side (p = 0.025 and p = 0.478). While in the control side woven bone 
was reduced to less than half as much, i.e. from 20.8% to 9.5%, in the HA side the 
reduction was limited to approximately one quarter, i.e. going from 26.3% to 19.2%. 
During the same time frame, lamellar bone significantly increased (p = 0.002 and p = 
0.017) in the control side from 3.2% to 7.8% and in the HA side from 1.4% to 4.4% 
(Fig. 15). Woven bone and newly formed lamellar bone added together was 
significantly higher (p = 0.038) with HA (23.6%) compared to the control side (17.3%) 
(Fig. 14). 
Contact rate of newly formed lamellar bone exhibited a significant increase in both 
sides between two and four weeks (p < 0.001 and p = 0.002) (Fig. 17). In the control 
side, the contact-rate of lamellar bone was considerably higher (25.4%) compared to 
the HA side (11.6%) (p = 0.005). The contact of woven bone to the implant surface in 
the HA side started to be substantially higher compared to the control side (38.1% 
and 47.0%, respectively), however not yet significantly (p = 0.113). The contact of 
newly formed bone (lamellar and woven bone added together) was not significantly 
different (p = 0.418) in the control side (63.6%) compared to the HA side (58.5%). HA 
particles represented a contact rate of 8.34% (Fig. 16). 
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 Six weeks after implantation: 
In the control side, lamellar and woven bone covered the implant surface. Lamellar 
bone was also in contact with the surrounding cancellous bone via newly formed 
trabeculae. Uneven and thin layers of lamellar bone outlined the surface. Compared 
to two and four weeks after implantation, less bone was observed (Fig. 24).  
 
Fig. 24: Control side (top and bottom): six weeks after implantation. Newly formed 
bone surrounded nearly the whole surface of the implant. Residues of epiphyseal 
cartilage embedded in newly formed lamellar bone (red arrows) (toluidine blue, 
original magnification x100). 
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Nearly the whole space between HA particles and between HA and implant surface 
was filled with woven bone. The lamellar bone membrane, surrounding the outside of 
the HA ceramic and woven bone aggregation, became thicker, especially in the 
proximal part of the threaded region. The bone-free surface was usually covered with 
marrow tissue (Fig. 25). 
Fig. 25: HA side (top and bottom): six weeks after implantation. Space between HA 
filled with woven bone (yellow arrows). Top: implant surface covered with HA and 
woven bone. Newly formed lamellar bone as thick layers, surrounded HA particles, 
woven bone and remnants of epiphyseal material (red arrows). Bottom: hardly any 
lamellar bone visible except thin layers on the outside of HA (toluidine blue, original 
magnification x100). 
 Neither the amount of woven nor the amount of lamellar bone showed significant 
differences compared to four week old specimens. In the control side, the amount of 
lamellar bone showed no differences compared to the HA side (7.4% and 5.2%, 
respectively), whereas the amount of woven bone was significantly (p < 0.001) lower 
(4.9% and 19.6%, respectively) (Fig. 15). The amount of woven and lamellar bone 
added together was significantly higher (p < 0.001) in the HA side (24.3%) compared 
to the control side (12.0%) (Fig. 14). 
While the contact rate of lamellar bone in the control side was not different between 
four and six weeks (p = 0.702), a decrease from 11.6% to 5.6% was detected in the 
HA side (p = 0.237). The opposite happened for woven bone: contact decreased 
from 38.1% down to 26.0% in the control side (p = 0.066), but no difference was 
detected in the HA side between four (47.0%) and six weeks (48.3%) after 
implantation (p = 0.998) (Fig. 17). The contact of newly formed bone (lamellar and 
woven bone together) decreased only significantly in the control side from 63.6% to 
50.3% (p = 0.028) compared to the HA side from 58.5% to 54.0% (p = 0.912). HA 
particles had a percentage contact of 13.1% to the surface of the implant (Fig. 16). 
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 Eight weeks after implantation 
In the control side, woven bone was surrounded of newly formed lamellar bone. A 
thin and uniform layer of lamellar bone outlined the implant surface. Hardly any 
trabeculae could be observed in the cancellous region (Fig. 26). 
 
Fig. 26: Control side (top and bottom): eight weeks after implantation. Lamellar bone 
covering widely the implant surface (red arrows). Some woven bone embedded in 
lamellar bone (yellow arrows). Few trabeculae and low amount of bone in the thread 
region were visible (toluidine blue, original magnification x100). 
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 In the HA side, the findings about woven bone were similar to those seen at six 
weeks after implantation. On the contrary, thick layers of lamellar bone were located 
on the outside of the peri-implant mantel consisting of HA particles and woven bone. 
Nearly the whole screw surface was covered with woven bone and HA particles (Fig. 
27). 
 
Fig. 27: HA side (top and bottom): eight weeks after implantation. Lamellar bone 
located marginally as a thick layer, which outlines HA particles and woven bone (red 
arrows). Space between HA completely filled with woven bone (yellow arrows) 
(toluidine blue, original magnification x100). 
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 In both sides, the amount of woven bone remained constant at the same value as at 
four and six week after implantation The amount of lamellar bone showed a 
significant increase in both sides, from 7.4% to 10.2% (p = 0.052) in the control side 
and from 5.2% to 9.0% (p < 0.001) in the HA side (Fig. 15). The amount of newly 
formed bone was significantly higher (p = 0.007) in the HA side (28.3%) compared to 
the control side (17.5%) (Fig. 14). 
The contact rate of woven bone showed a continuous, but not significant increase in 
the HA side up to 59.2% (p = 0.174), while in the control side the contact rate 
returned to almost the same value as at week 4 (39.1%) (Fig. 17). The contact rate of 
lamellar bone remained constant in both sides. The contact rate of lamellar and 
woven bone added together was not different between both sides at the end of the 
study (63.0 and 66.5%, control and HA side, respectively, p = 0.456). The contact 
rate of HA ceramic represented 10.3% (Fig. 16). 
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 1.2. Longitudinal bone growth 
Within eight weeks of the experimental period, a longitudinal bone growth of nearly 
1,35 mm was measured between the screw-axis and the proximal growth plate of the 
tibia (Fig. 28). The growth was mainly linear with an approximate rate of 175 µm per 
week. 
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Fig. 28: Longitudinal bone growth during experimental period (rat age from week 16 
till week 24). 
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2) Qualitative Analysis 
Over the whole experimental period, a large amount of different bone marrow cell 
types with different morphologies i.e. lymphocytes, neutrophils, eosinophils and 
macrophages with their precursor cells were detected. As expected, the bone 
marrow of still growing, not yet adult rats (as used in our experiments) was very 
active and showed a dense cellular population at all time points. 
As quantitatively assessed in sections stained with toluidine blue, woven bone 
formation was observed between HA particles and in direct contact with the implant. 
Woven bone formed a unique mass by connecting HA particles with each other. 
Bone marrow and few fat cells filled up the space between HA particles where woven 
bone was missing. At all time points bone marrow showed similar cellular activity: no 
specific or acute signs of inflammation or fibrosis were detected (Fig. 29). 
 
Fig. 29: Two weeks after implantation: HA side: Newly formed woven bone 
surrounding HA particles using them as a pattern (Giemsa/Eosin, original 
magnification x200 and x500). 
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A thin layer of non- or less mineralized bone matrix was observed, surrounding 
preexisting cancellous bone, starting two weeks after screw and HA insertion. Many 
active osteoblasts were detected concentrated two weeks after implantation. This 
fact corroborates the observation obtained with the quantitative analysis, whereby the 
largest amount of woven bone was produced in both sides in the first two weeks after 
implantation. The osteoblasts outlined bone surfaces as well as HA particles and 
produced the organic portion of bone tissue matrix (i.e. osteoid), whose structure 
defined by the collagen fibers was well organized. Remnants of epiphyseal cartilage 
material were also identified. They were surrounded by cancellous bone and newly 
formed bone material, as already visualized in the samples stained with toluidine blue 
(Fig. 30-33). 
 
Fig. 30: Two weeks after implantation: control side: Osteoblasts outlining bone 
surfaces and producing osteoid (red arrows). Remnants of epiphyseal material 
(yellow arrow) surrounded both of preexisting cancellous bone and osteoid 
(Giemsa/Eosin, original magnification x200). 
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Fig. 31: Two weeks after implantation: control side (A) and HA side (B): Many active 
osteoblasts outlining HA and bone surfaces and producing osteoid. B: Preexisting 
cancellous bone displaced in the outer region of the ROI. HA particles between the 
threads of the screw. (Giemsa/Eosin, original magnification x200). 
 
Fig 32: Four weeks after implantation: control side (A) and HA side (B): Less active 
osteoblasts visible compared to week 2. A: Layer of newly formed bone surrounding 
implant surface. Osteoid produced by osteoblasts along bone surfaces. B: Newly 
formed woven bone outlining HA and screw surface (Giemsa/Eosin, original 
magnification x200). 
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Fig. 33: Six weeks after implantation: In the control side (A) less amount of woven 
bone visible compared to the HA side (B), where woven bone filled up the whole 
space between HA particles. Less active osteoblasts visible, mostly outlined of the 
bone and still producing osteoid (Giemsa/Eosin, original magnification x200). 
 
Remodelling units consisting of active osteoclasts and osteoblasts were also 
observed, especially at week 4, i.e. following the bone formation period. In the course 
of the healing process, preexisting cancellous bone, embedded epiphyseal material 
and woven bone were continuously remodelled into lamellar bone. While the 
osteoclasts resorbed bone tissue, in close proximity osteoblasts secreted new bone 
matrix (Fig. 34).  
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Fig. 34: Four weeks after implantation: Remodelling sequences: toluidine blue (A-C), 
Giemsa/Eosin (D): Osteoblasts secreting new bone matrix (red arrows: A, C, D). 
Osteoclasts (yellow arrows: B, D) performing bone resorption, visible through the 
ruffled border that seals the compartment for bone degradation (oval: A, B, D) 
(original magnification x200 and x500). 
D
 DISCUSSION 
Loss of the surgical construct stability as a result of screw loosening is a well-known 
complication in osteoporotic patients. More than 50 % of proximal humerus fractures 
have fair or poor results because of screw loosening and pull-out from the humeral 
head [25]. Internal fixation of intertrochanteric fractures fails in 10% of cases because 
of cut-out of the lag screw from the cancellous bone of the femoral head [26]. The 
number of hip fractures, for example, that occur each year in the world has been 
estimated to be 1.66 million in 1990 and is predicted to rise to 6.26 million by the year 
2050 [27,28]. The need of improved implant stability in osteoporotic bone is obvious 
and several methods have been developed to address this problem.  
This study was designed to examine if HA particles were able to alter remodelling 
processes around implants inserted in osteoporotic bone. Based on an 
ovariectomized mature rat model, the results clearly demonstrated that the presence 
of HA particles inhibited resorption of woven bone starting between two weeks after 
screw implantation: A significantly denser peri-implant bone mantel was maintained 
and more extensive bone-implant contact was measured over the whole duration of 
the study, which are both critical parameters for improved implant osseointegration. 
Data from pQCT-measurements verified the appropriateness of our rat model 
[29,30,31]. An osteoporotic state was successfully induced, corresponding to a mean 
decrease in bone mineral density of 33,9% at the distal femoral metaphyses four 
weeks after ovariectomy compared to age-matched sham-operated animals. This 
result stands in good agreement with previous publications [32]. In respect to our 
hypothesis, results from the histologic analysis evidenced that after the initial bone 
formation phase for about two weeks, the amount of woven bone surrounding the 
screw decreased in both sides (i.e. with and without HA particles) as a typical 
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 consequence of bone resorption processes and increased bone turnover following 
ovariectomy [33,34]. The bone loss affected pre-existing cancellous bone as well as 
newly formed bone trabeculae [14]. However, this decrease was significantly reduced 
in the HA side: more than twice of the amount of woven bone remained in the peri-
implant region until the end of the experimental period compared to the control side. 
Moreover, HA particles also induced more contact of new bone with the implant 
surface. Despite the substantial space occupied by the inserted HA particles, the 
total percentage of screw perimeter covered by bone tissue was nearly the same 
amount in both sides at all time points. When we normalized the contact rate results 
to the available surface perimeter, new bone had more contact to the implant surface 
in the HA side compared to the control side. Hence, not only did HA particles induce 
more bone formation but they apparently promoted more bone deposition directly on 
the implant surface till the end of the experimental period. These results corroborates 
with previous studies where the good biocompatibility as well as the osseoconductive 
and osseoinductive properties of HA particles in rat bone were assessed [35,36,37]. 
The novelty of our study concerning the use of HA is twofold: besides testing a new, 
simple technique that took advantage of the known bioactive properties of HA, we 
also monitored the effect of those particles at different time points during the bone 
healing processes in an osteoporotic rat model. Instead of performing a complex 
coating process [24,29], small HA particles were inserted in a predrilled hole before 
implant placement. The absence of any signs of inflammation suggested that this 
surgical technique could be quite a conceivable alternative in clinical settings too. In 
previous studies the effect of HA was mainly tested on coated implants using normal, 
healthy animal models (i.e. lacking the bone turnover affected by osteoporosis) 
[38,39,40], or in osteoporotic animals but only at one time focussing on long-term 
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 effects, disregarding the bone formation processes in the healing phase after surgery 
[41,42]. 
Previous studies have reported transient effects of HA in coatings: its stimulatory 
effect at early time periods diminished with time. Mechanical tests on HA-coated 
implants were consistent with these findings [40]. Our data also demonstrate that 
more bone was formed during the first two weeks of the healing phase (i.e. bone 
formation phase), but HA particles seemed to affect more distinctively the 
remodelling phase leaving more woven bone in the peri-implant region. The rather 
continuous and linear bone layer covering the implant in the control side might be 
more exposed and vulnerable to osteoclastic activity. By contrast, woven bone 
embedded between HA particles could be guarded against resorption by partially 
blocking access to larger cells like osteoclasts. 
The fate of this additional amount of woven bone after the experimental period is not 
known. In rat models the remodelling processes are usually in an advanced stage at 
eight week after surgical procedure. However, the reduced amount of lamellar bone 
in the HA side points to a delay in this biological cascade. In the control side, 
remodelling processes were observed around the implant surface and around pre-
existing trabeculae, whereas in HA side newly formed lamellar bone was missing 
around implant surface [43,44,45] and between HA particles. Most of the lamellar 
bone was detected around the structure consisting of screw, woven bone and HA 
particles. 
Regarding the functionality of the effect induced by HA particles, unfortunately the 
experimental design in this study did not permit to carry out mechanical tests on 
paired samples, which should be included in future studies. Moreover, the location 
used for implantation, i.e. cancellous versus cortical bone, will affect the course of 
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 osseointegration, because trabeculae offer a larger surface compared to the cortex 
[8,46]. To avoid mixed effects, we limited our analysis to the threaded part of the 
screw and discarded the tip, so that at all time-points only cancellous bone would be 
in contact with the surface. Due to normal axial growth of the limb in still growing 
mature rats [47-52], screw moved distally and at later time points (six and eight 
weeks) most of the tips were anchored in the cortex.  
In summary, this study demonstrated that non-resorbable HA particles were able to 
maintain significantly peri-implant bone material in osteoporotic trabecular bone. The 
presence of HA particles affected remodelling processes and improved 
osseointegration. This effect may play an important role in the prevention of implant 
loosening and cut-outs in clinical cases. 
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